Truffle Capital

SCOR Ventures is the venture investment arm of SCOR Reinsurance, responsible for both investing in and creating partnerships with startups across the insurtech landscape. Since 2017 we have built a global portfolio across three theses: (1) investing in tech-driven underwriting companies (MGAs, carriers) and distributors, (2) software solutions that benefit SCOR and/or our clients, and (3) companies that help people live healthier lives. Our investment scope includes both investments and commercial (re)insurance relationships with startups. We predominantly invest at late Seed / Series A and are interested in a broad range of B2B and B2B2C solutions across MedTech, wellness, wearables, data platforms, and software / AI platforms. What we’re looking for We invest across three thesis areas: Thesis 1: we invest and partner in the ‘Insurers of the Future’: tech-driven underwriting companies (MGAs, carriers) that offer multiple points of digital and business model differentiation across P&C and L&H. We provide direct access to SCOR expertise and our global network to help portfolio companies scale and/or access (re)insurance capacity. With a proven track record of supporting innovative underwriting propositions across multiple lines of business, we understand product development, program structuring, underwriting, pricing and distribution and thus have the capabilities to optimise partnerships between insurtechs and business partners. We predominantly invest at late Seed / Series A. We are class of business agnostic and have partnered with companies across a broad variety of personal and specialty lines. Thesis 2: we invest and partner in software solutions that benefit SCOR and/or our clients. We provide a broad understanding of the interests and pain points of insurers across the world, and the potential to connect companies with insurers through SCOR’s client services initiatives. We predominantly invest later stage vs. Thesis 1 (typically Series A-B) but have occasional appetite for Seed. We prioritise companies: developing data, tools, and methods for obtaining, understanding, pricing and transferring large portfolios of pre-aggregated risks, high-value individual risks such as energy facilities and construction mega-projects, and MGA/coverholder business delivering economically valuable additional services offering a visible outcome which can be used to boost client management or reduce risks. Focus areas include front-end (e.g., underwriting & pricing) policy administration, modelling, risk analytics, and claims developing platforms where insurance has not previously been embedded / distributed, but where SCOR Ventures sees substantial opportunities to close the global protection gap – e.g., marketplaces, “super apps”, b2b fintech, employee benefits working to solve climate and ESG challenges to support the net zero transition and cut emissions for SCOR and SCOR clients. Focus areas include ESG reporting, climate risk analysis and data, carbon offsetting as a solution, circular economy, diversity, equity, and inclusion (DEI) tech, and supply chain transparency. We also see several opportunities in the green insurance product space including solar production or maintenance guarantees, wind input parametric products, solar physical asset damage, cat-bond / ILS and insuring carbon credit projects. Thesis 3: We invest at the intersection of health and technology and partner with companies that help people live healthier lives, deliver in-force or claims outcome improvements, develop new business or add to SCOR’s Knowledge Center capabilities, and assist our clients to transform their offerings. We predominantly invest at late Seed / Series A and are interested in a broad range of B2B and B2B2C solutions across MedTech, wellness, wearables, data platforms, and software / AI platforms. How we operateIntegrated in the wider SCOR business: Direct access to the entirety of SCOR’s capabilities brings unique added value to our portfolio companies. SCOR’s core business has experts in nearly every country, line of business, and functional area, while SCOR Partners bring a broad range of client services, marketing and product development expertise. Mandate: focused on key markets in North America, EMEA and LATAM, with selective deployment in APAC and Africa. Stage and ownership: We invest Seed to Series B. We typically seek greater than 5% ownership at first investment, which may include a board seat (we have led or co-led half of our investments to date). Our investment is intended to make SCOR a meaningful contributor but leave founders room to manage their cap table. We look for a long-term investment and / or commercial relationship but do not seek a fast exit or to ultimately acquire portfolio companies. Partnership approach: we are active supporters of the companies we work with, assisting with technical input, recruitment, capital optimisation and more. The material growth of many insurtech MGAs and carriers has led to increasing demand for (re)insurance capacity; SCOR is a transparent, long-term partner. Insurtechs in SaaS and services segments, meanwhile, have benefited from SCOR’s long-standing client relationships, while SCOR benefits from bringing knowledge, links, and expertise regarding services with genuine value to our clients. We bring value to our portfolio companies by connecting them with other partner companies, as well as with founders and distribution leads in our network. Why partner with SCOR VenturesWe believe in fewer, deeper relationships over the long term. We are flexible and collaborative in our approach, tailoring a solution to your specific needs, in partnership with other insurers, reinsurers, and investors involved in your company as appropriate. We underwrite most major lines of business and geographies globally. We have a global network including insurance licenses but not a competing retail insurance arm. Insurers are our clients, so working with us does not limit your options to associate with insurers. In selected circumstances, we can offer access to Lloyd’s or SCOR’s insurance licenses in the U.S., Europe, Asia, Brazil, South Africa, and other markets. We look to move quickly with direct access to decision makers, whilst leveraging resources and expertise to ensure our partners can build relationships with the appropriate parts of our organization.

Focused on the rising consumption story in India and Indian SaaS companies catering to a global market. CONSUMER TECH Backing tech native businesses for India’s internet users and middle-class. AgriTech EdTech HealthTech SOFTWARE AS A SERVICE (SAAS) Backing product-led SaaS startups that can reach a global scale. Automation, Collaboration and Intelligence Vertical SaaS SaaS enabled marketplaces FINTECH Backing companies which manage finances in the most tech efficient way Vertical neo banks, lending Embedded Finance, infra APIs Insurtech Alternative investing DEEPTECH Backing companies solving deep engineering problems Artificial Intelligence Robotics / Drones Space tech and Semiconductors OUR APPROACH We invest in people rather than companies. From great entrepreneurs emerge great brands and companies. We are good listeners and that is a trait needed in our profession to grow. We have a non-intrusive approach and we completely believe in the entrepreneurs we have backed. An entrepreneur can think of us more as a resource and a sounding board. WHAT WE LOOK FORWe prefer to invest in mission driven founders who have relevant work experience and domain expertise Significant growth potential over the next 3 to 5 years. We prefer backing founders with at least 4-5 years of prior experience. Differentiated products or services that have strong ‘moats’ built around it. HOW WE INVESTWe invest in pre-seed and seed rounds. We invest ~US$ 250K per startup in the first round and then in follow-on rounds We are open to investing through convertible structures and instruments, however, we prefer straight equity. We generally prefer to co-invest along with other VC funds and micro VC funds In a larger round of fundraising – we co-invest with our select Limited Partners.

We invest with a cross-border strategy in mind and act as a financial investor as well as the cross-border partner for our investees. Our main investment thesis is to invest in Chinese tech companies and exporting their technology and expertise from China to Southeast Asia. Then, we also invest in Southeast Asian tech companies by referencing to proven business models and strategies of tech unicorns in China. We are accredited by the Securities Commission of Malaysia as a private equity management corporation and have been granted "Type 9: Asset Management License" by Hong Kong Securities and Futures Commission to carry out venture capital and private equity investments. What we can do Our Investment thesis falls under the ideal that we are able to not only be your financial investor, but also an active partner in your journey as a startup Regional Expansion: With a wide range of local partners in China and ASEAN, we utilize our networks to open new relationship for collaborations or partnerships. We also assist in sourcing for local talents and provide business intelligence for setting up regional hubs. Active Strategic Assistance: We are constantly looking at angles or partnerships that would transfer market know-how and proven business models to our investees. Through our monthly meetings, we would discuss any ideas or problems and aim to actively assist each investee in their journey to grow the company. Regional Exit Channel: We line up investees for subsequent rounds of fundraising and position investees for exit to regional tech giants (Alibaba, Tencent, Lenovo, Didi). We assist in connecting startups and advising on any acquisition proposal. What stage and how much do we invest?We invest at the Series A to B. We typically look at companies raising from USD$1M to USD$5M. However, we do invest at seed stage as well, if there is a strategic angle for our portfolio. We prefer to lead rounds and work with co-investors that adds value to the investee Which regions do we invest in?We invest regionally from China to Southeast Asia. We are always looking for startups that aim to expand regionally. What industries do we invest in?We are sector agnostic, however, we do have a preference for startups that are disrupting traditional industries such as fintech, insurtech, e-commerce, digital health and education tech companies. What is a PE/VC hybrid firm?Traditional VC firms provide minimum value creation post-investment, while we continue to provide values and aid our investee throughout their growth stage Thus, we are a VC that applies PE portfolio management style What should you prepare to pitch your company?We would love to hear how you evolved from your founding team and elaborate on the industry. We would like to know the in and outs of your business model and how you would like to scale the company with funding All the available metrics to evaluate your business would be helpful in further understanding your business position. And, we would like to hear your vision of your company in the next few years. You are looking to expand regionallyWe would be your cross-border partner in terms of crossing from China to Southeast Asia and also within countries in Southeast Asia We are always looking to connect our investees with strategic partners in the region

The most powerful ideas, companies, and industries aren’t created overnight. With a community built on collective experience and fueled by curiosity, Slow understands the entrepreneurial journey. Investing at the center of technology and on the edges of science, society, and culture, Slow gives curious founders the resources, connections, experiences, and empathy required to build strong, sustainable companies. We are generalists and invest in early stage teams and ideas ranging from Social Networking to Consumer Brands to SaaS, and Crypto. We believe - and have seen proven time and again - that great things frequently take time to inflect, and believe that our number-one job is to back great founders on their journey. In the last ~decade we have invested in the earliest rounds of over 500 companies, including… Consumer-Ish Nextdoor Private social network for your neighborhood Hipcamp Discover and book the best campsites in California Postmates Same day urban delivery platform Birchbox Subscription commerce for beauty products Allbirds Environmentally friendly footwear. Casper Digitally introduced brand of mattresses. Birdies Fashionable women’s slippers. BarkBox Subscription commerce for dogs Even Interest-free credit to keep your paycheck steady. Citizen People protect each other Good Dog Find puppies from responsible breeders. Fintech-Y Robinhood Mobile stock brokerage Venmo Social payment app Teamshares employee ownership for small business. Eco One balance to save, spend, and make money HM Bradley Unlock your money’s potential VGS Payment data security & compliance infrastructure Human Interest 401(ks) for SMBs Astra The Automation Platform for Money Movement Wax Insurance Protect your passion SaaS-Ie Airtable Modern database software. Domino Data Lab Enterprise data science platform. Frontapp Customer management platform Tonkean Next generation management platform. Otter AI-powered voice translation app. OpenPhone Mobile app for a business phone number Slack Work messaging Amplio Risk prediction & component sourcing Consumer-Medical-Ish Ro Direct-to-consumer telehealth. Livongo Health Personalized Tools for Chronic Condition Management Plume Gender-Affirming Hormone Therapy From Anywhere Pillpack Simplified Pharmacy Fairsquare Medical Your Medicare One-Stop-Shop Wheel powering virtual care Brightside online treatment for depression and anxiety Embark Dog DNA & health testing Flossy For patients without dental insurance Creator-Y Juice Banking trusted by the best creators Stem distribution and payments for musicians Human DAOs lead by creators Pearpop creator collaboration on demand Real-World-Ish Astra Lower cost rocket launches. Common Technology-enabled residential operator. Running Tide Automated ocean harvesting technologies. Zipline Global on-demand delivery. Metropolis mobile commerce and modern parking Pollen Own your network Crypto Solana Scalable blockchain infrastructure. Klaytn The Ground for All Blockchain Services Chia A new blockchain and smart transaction platform Aleo Where Applications Become Private. Algorand A pure proof of stake blockchain platform. Diem A trusted and innovative financial network. Ampleforth The rebasing currency. Lightning Labs layer-two bitcoin. Fold Wallet Bitcoin wallet. River The best place to buy, sell BTC And Many More….

RA Capital Management is a multi-stage investment manager dedicated to company formation and evidence-based investing in healthcare and life science companies developing drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. We are committed to fostering diversity at RA, in our portfolio companies, and in the broader biotech community. Who We AreOur flexible strategy allows us to provide seed funding to startups and lead private, IPO, and follow-on financings for our portfolio companies, thereby driving value creation from idea inception through commercialization. At RA Capital’s core is its TechAtlas research division, a scientifically trained team that maps out competitive landscapes to put data into context, identify breakthroughs, and originate conviction in new ideas. TechAtlas provides market intelligence and, technical diligence, and other resources to both our internal Investment Team and our portfolio companies. The team’s understanding of industry best practices is derived from an extensive collection of case studies documenting the impact of clinical trial design, partnership structures, and public market dynamics. Beyond CapitalRA Capital offers its portfolio companies much more than capital to help them grow, make decisions, and succeed. We:Serve on boards of private and public companies and host board meetings at our offices Help recruit executives and board members Provide access to TechAtlas maps and expertise Prioritize indications and targets based on their feasibility and value given current scientific knowledge, unmet needs, and emerging competition Monitor for new applications and complementary technologies Create custom maps that lay out a company’s competition and unrealized opportunities Provide extra analytical bandwidth across our large team (e.g., analyze literature, provide insights from scientific and investor conferences) Assist with grant writing and preparation of scientific publications Interview clinicians and key opinion leaders (KOLs) Host advisory boards Facilitate partnership or acquisition discussions with larger companies Help design (or redesign) a corporate slide deck or website, leveraging in-house writing and graphics teams Make introductions to other investors Anchor subsequent financings and set the pace for closing Help select bankers for financings and M&A We also provide a growing suite of Innovator Resources to the broader ecosystem, with more hands-on support for our portfolio companies, management teams, and boards. These resources include: a comprehensive reference guide to conducting successful biotech board meetings; a data-driven guide to how to conduct a logical IPO based on first principles of price discovery and shareholder alignment; and a roadmap for how to convey your company’s unique Equity Value Proposition to employees (because they are also your investors). We’re available to coach you through a pitch, provide feedback on a deck, and partner with you to refine strategy or messaging at every stage. Additionally, we helped to found and continue to support No Patient Left Behind, a non-profit dedicated to promoting affordability of today’s medicines and the development of better ones. More specifically, NPLB advocates for insurance reforms that would allow all patients to afford the treatments they need, draws attention to the full societal value of all medicines and the merits of ensuring that all drugs go generic without delay, and educates lawmakers and the public about the workings of the biomedical ecosystem to protect it against misguided policies. Translation & HuntingRA Capital offers Executive-In-Residence (EIR) and venture partner programs for experienced professionals seeking thought partners. We welcome experienced drug hunters searching for technologies/candidates and looking to start new companies to collaborate with our team, explore the capabilities of our in-house incubator, and take advantage of the breadth and depth of our TechAtlas platform. RAVen, our in-house incubator, provides a collaborative platform for drug hunters and company builders to explore both the novel and the re-imagined. Discoveries and improvements in chemistry, molecular and cellular biology, and materials science create novel capabilities that may address unsolved challenges. Our understanding of fundamental biology is constantly evolving, revealing new applications for existing technologies and partially-developed drug candidates. Programs we consider worthwhile may form the basis for a new venture. We believe that when a business proposition is framed correctly, the capital markets have adequate resources and understanding to fund proper experimental design and solution development without forcing companies to cut corners. Furthermore, we have collaborated extensively with other funds that share our philosophy to enable ambitious and capital-intensive endeavors. Our ValuesWe at RA Capital are introspective and deliberate about the ways in which we engage with each other and those outside our firm. Our values represent a set of clear parameters by which we create working relationships founded on trust, collaboration, diligence, and integrity.We originate conviction. We do not borrow it from others. We expect and strive to inspire the best in everyone. We embrace the unfamiliar. We do not let convention stand in the way of what is right. We learn collaboratively. We have a bias for action. We are persistently curious and humbled by what is left to learn. We are data-driven and challenge assumptions. We preserve the ability to change our mind. We admit our mistakes and share lessons learned. We address the elephant in the room. We value our relationships and are positive, respectful, and open-minded. We take fun seriously.

Established in 1999, iGlobe Partners was founded by Soo Boon Koh in Silicon Valley after she was tapped by Singapore’s government to set up and manage the operations of a corporate venture in the United States and Europe for more than a decade. In 2009, she headquartered the company in Singapore, pioneering the country’s Venture Capital (VC) scene with Singapore’s first female-led VC firm. Since then, iGlobe has become a premier global VC with a strong track record of enabling startups to scale game-changing innovations. Our funds have continually achieved top-quartile performance and have birthed multiple unicorns for our founders and successful exits for our investors. We value genuine partnership and integrity. Our roots lay in our passion for technology and a desire to change the world for the better. Embracing every aspect of diversity, we scour the globe for visionary founders from diverse backgrounds. We aim to build the future by unearthing, investing in and growing promising startups to become leading pioneers in their field. We work with our founders in every step of their journey. Let iGlobe be part of yours. Our Values We understand your desire to change the world for the better and we make sure your VOICE is heard. Value Creation: We have decades of experience through multiple market cycles, delivering superior returns and driving meaningful tech advancement. Openness: We love to hear about game-changing technologies and new ideas from driven entrepreneurs and industry leaders from all backgrounds. Integrity: We cultivate long-term relationships built on integrity and trust, as founders’ investor of choice and investors’ trusted fund manager. Connecting: We connect deeply and extensively, inspiring all to achieve their fullest potential through our mentoring, experience and commitment. Empowering Tech: We unearth and support technologies that empower individuals, revolutionize industries and build a sustainable world for the future. Our Investment Focus We welcome you to join us in shaping the future we envision. The Future of Cities: PropTech, Mobility, Metaverse, Media, Robotics… The Future of Money: Digital Banking, Financial Inclusion, Payment, Insurtech, DeFi… The Future of Bio: Climate Change, Renewable Energy, Food & Agriculture, Materials, Diagnostics… The Future of Health: Digital Health, Health & Wellness, Lifestyle, Diagnostics & Therapeutics, Precision Medicine…